ENBIO Co., Ltd. (KOSDAQ:352940)
2,010.00
0.00 (0.00%)
At close: Jun 30, 2026
ENBIO Revenue
ENBIO had revenue of 14.14B KRW in the quarter ending March 31, 2026, with 2.24% growth. This brings the company's revenue in the last twelve months to 34.26B, up 1.15% year-over-year. In the year 2025, ENBIO had annual revenue of 33.95B, down -4.77%.
Revenue (ttm)
34.26B
Revenue Growth
+1.15%
P/S Ratio
0.64
Revenue / Employee
428.29M
Employees
80
Market Cap
21.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 33.95B | -1.70B | -4.77% |
| Dec 31, 2024 | 35.65B | 1.63B | 4.79% |
| Dec 31, 2023 | 34.02B | -215.53M | -0.63% |
| Dec 31, 2022 | 34.24B | 773.80M | 2.31% |
| Dec 31, 2021 | 33.47B | -1.10B | -3.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Humax | 388.31B |
| PC Direct | 384.72B |
| Moorim SP | 216.55B |
| Hurum | 96.85B |
| AUTO& | 57.35B |
| CU Medical Systems | 54.66B |
| Beauty Skin | 48.74B |
| Coloray International Investment | 44.55B |